Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Politics

Rachel Levine proves YET AGAIN she’s America’s No. 1 gender extremist

by July 1, 2024
July 1, 2024
Rachel Levine proves YET AGAIN she’s America’s No. 1 gender extremist

Adm. Rachel Levine — a transgender assistant secretary for health in the Biden administration — has long been among the most extreme of the gender extremists in American public life, but new documents reveal she’s even more fringe than we knew.  

Levine got wind that World Professional Association for Transgender Health, itself a hardcore lefty advocacy group helping drive the current gender crisis in America, was going to (gasp!) set recommended age minimums for gender-based medical interventions in its 2022 guidance.

She came down like a hammer, reaching out through backchannels to interfere. 

WPATH wanted a minimum age of 14 for hormone treatment, 15 for mastectomies, 16 for breast augmentation and 17 for genital surgeries. 

Levine wanted no limits whatsoever … especially for the surgeries. 

But why the backchannel outreach? She’s the face of Biden’s transgender policy posture, after all.

Per an email revealed in a recent court filing, Levine was ‘confident, based on the rhetoric she is hearing in D.C., and from what we have already seen, that these specific listings of ages, under 18, will result in devastating legislation for trans care.’ 

In other words, if WPATH conceded an inch to medical reality, it might hurt Levine’s boss Joe Biden politically.

And WPATH, not shockingly, reportedly broke its own rules and defied the wishes of its own committee members to oblige this high-ranking and powerful government official (who plainly has the support of the president, or whoever makes decisions in this White House). 

Remember: WPATH is, by any normal standard, about as far out there as it’s possible to get on trans issues. 

Even as European nations and Britain have rightly turned away from the idea that kids should have a greased path to medical intervention for gender dysphoria — interventions that can have brutal lifelong effects, like infertility — WPATH stubbornly holds on. 

Despite the heartbreaking testimony of brave detransitioners like Luka Hain and Chloe Cole, failed totally by the medical establishment. 

But even that outfit was too moderate for Levine, and its minor gesture at sane policy had to be swept away to aid national Democrats. 

This is what results when you let fanatics literally living out their ideology effectively set policy on a truly difficult issue. 

Extremists like Levine customarily claim that trans people are marginalized, at risk, oppressed by society, etc., so they must be given everything they want as soon as they ask for it no matter how nonsensical. 

That concept then gets enshrined in policy and medical guidance and every other official posture.

In fact, the opposite is true. 

Witness the fate of brave whistleblowerslike Eithan Haim, the Texas surgeon now facing four felony charges for bringing to light the unethical and possibly illegal activities of doctors at America’s largest children’s hospital. 

Or Jamie Reed, who was attacked by the ACLU for doing the same thing at a St. Louis gender clinic.

No, the power is (for the moment) on Levine’s side as she maneuvers to sweep away all guardrails around protecting kids from medical disasters. 

Which is precisely what makes the good fight against her and her brothers-in-arms so essential. 

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Fetterman cites own ‘difficult’ debate in arguing Biden can still win, slams Democrats ‘defecting’ to Trump
next post
‘Woke’ universities put on notice for allowing ‘disgraceful mob riots’ in new GOP bill

Related Posts

In State of the Union speech Biden showed...

March 8, 2024

Israel announces partial troop withdrawal from Gaza in...

January 1, 2024

Sketch artist responds after critics rebuff him for...

June 19, 2023

Iranian president’s wife says hijab law done ‘out...

September 25, 2023

DOJ weighing potential charges against Bob Menendez following...

August 27, 2023

US refrains from placing preconditions on weapons sent...

October 18, 2023

Kamala Harris ratings continue to plummet as 2024...

February 8, 2024

Biden admin faces bipartisan backlash for allowing beef...

February 28, 2024

Top Virginia Democrat defends candidate who streamed sex...

September 16, 2023

NYC Mayor Adams slams ‘right to shelter,’ says...

August 10, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The NASDAQ 100, On The Brink Of A Breakout, Needs Help From This Group

    • Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub

    • Editor’s Picks: Silver Price Hits 13 Year High, Gold Takes a Breather

    • Joe Rabil’s Undercut & Rally Pattern: From DROP to POP

    • RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New Rally?

    • Coelacanth Energy

    Categories

    • Business (1,259)
    • Investing (2,585)
    • Politics (3,699)
    • Stocks (1,670)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved